ASCO GU 2023 Conference Coverage

 

ASCO GU 2023 Conference Coverage
A

ASCO GU 2023 Phase 3 IMvigor130 Study: Final OS Analysis of Atezo Monotherapy vs. Chemo in Untreated Locally Advanced or Metastatic Urothelial Carcinoma

By ASCO GU 2023 Conference Coverage FEATURING Aristotelis Bamias
By ASCO GU 2023 Conference Coverage FEATURING Aristotelis Bamias
93 views
February 28, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh
Videos
07:52

Independent Biomarkers Predictive of Outcomes With Enfortumab Vedoti…

ASCO GU 2023 Conference Coverage

T. Jindal

98 views
06:49

ASCO GU 2023 DEAR Study: Real-World Use of Darolutamide, Enzalutamid…

ASCO GU 2023 Conference Coverage

D. George

373 views
12:39

Efficacy and Safety of Darolutamide in Combination With ADT and Doce…

ASCO GU 2023 Conference Coverage

C. Sternberg

1.4K views
08:18

ASCO GU 2023 Real-World Effectiveness of Darolutamide in mCRPC

ASCO GU 2023 Conference Coverage

A. Liang

123 views
05:39

ASCO GU 2023 Analysis of the UNITE Study: Biomarkers of Response to …

ASCO GU 2023 Conference Coverage

T. Jindal

103 views
11:07

ASCO GU 2023 Innovative and Pragmatic Methods to Study BCG-Unrespons…

ASCO GU 2023 Conference Coverage

J. Gore

51 views
07:09

ASCO GU 2023 HER2 Expression in Urothelial Carcinoma

ASCO GU 2023 Conference Coverage

V. Koshkin

87 views
07:23

ASCO GU 2023 Response & Outcomes of Maintenance Avelumab After Plati…

ASCO GU 2023 Conference Coverage

P. Grivas, D. Bakaloudi

253 views
10:44

ASCO GU 2023 Additional Results From the Randomized Phase 2 CheckMat…

ASCO GU 2023 Conference Coverage

R. Pachynski

305 views
07:06

ASCO GU 2023 JAVELIN Bladder 100 Trial: Avelumab 1L Maintenance for …

ASCO GU 2023 Conference Coverage

K. Sridhar

261 views
05:40

ASCO GU 2023 International Phase 3 Randomised Controlled PACE-A Tria…

ASCO GU 2023 Conference Coverage

N. van As

101 views
08:32

ASCO GU 2023 Real-World Assessment of AR-LBD Mutations in mCRPC

ASCO GU 2023 Conference Coverage

E. Antonarakis

64 views
07:36

ASCO GU 2023 Assessment of Clavien-Dindo Classification in Patients …

ASCO GU 2023 Conference Coverage

K. Runcie

88 views
05:31

ASCO GU 2023 Phase I/II AlphaBet Trial: Evaluating the Combination o…

ASCO GU 2023 Conference Coverage

A. Azad

59 views
04:34

ASCO GU 2023 Phase I/II LuCAB Trial: Evaluating Cabazitaxel in Combi…

ASCO GU 2023 Conference Coverage

A. Azad

135 views
05:20

ASCO GU 2023 Efficacy of Systemic Therapy Following [177Lu]Lu-PSMA i…

ASCO GU 2023 Conference Coverage

A. Azad

131 views
03:05

ASCO GU 2023 Adjuvant Therapies in Renal Cell Carcinoma: Are New Dat…

ASCO GU 2023 Conference Coverage

M. Zibelman

264 views
05:47

ASCO GU 2023 Outcomes by IMDC Risk in the COSMIC-313 Phase 3 Trial: …

ASCO GU 2023 Conference Coverage

T. Powles

211 views
07:03

ASCO GU 2023 Real-World Evidence From Four High-Volume Institutions:…

ASCO GU 2023 Conference Coverage

O. Caffo

42 views
10:24

ASCO GU 2023 Real-World Data from an Italian Multicenter Observation…

ASCO GU 2023 Conference Coverage

O. Caffo

47 views
07:49

ASCO GU 2023 First Analysis From an Italian Multicenter Observationa…

ASCO GU 2023 Conference Coverage

O. Caffo

109 views
12:48

Cost-Effectiveness Analysis of Seven Treatment Regimens in mHSPC: A …

ASCO GU 2023 Conference Coverage

M. Kohli

243 views
07:53

ASCO GU 2023 Phase 3 IMvigor130 Study: Final OS Analysis of Atezo Mo…

ASCO GU 2023 Conference Coverage

A. Bamias

93 views
13:01

ASCO GU 2023 Interim Analysis of the Prospective Phase II COTRIMS Tr…

ASCO GU 2023 Conference Coverage

A. Heidenreich

94 views
09:47

FDA Announcement Based on the MAGNITUDE Trial: Niraparib With Abirat…

ASCO GU 2023 Conference Coverage

E. Efstathiou

197 views
01:46

ASCO GU 2023 Randomized Double-Blind Phase 3 KEYNOTE-921 Study: Pemb…

ASCO GU 2023 Conference Coverage

D. Petrylak

281 views
08:45

ASCO GU 2023 Machine-Learning to Predict Utility of ctDNA for Somati…

ASCO GU 2023 Conference Coverage

C. Herberts

29 views
04:49

ASCO GU 2023 Updated Outcomes in TROPHY-U-01 Cohort 1-A Phase 2 Stud…

ASCO GU 2023 Conference Coverage

S. Tagawa

167 views
05:48

ASCO GU 2023 Randomized Double-Blinded Phase II Study of Keto HC and…

ASCO GU 2023 Conference Coverage

S. Tagawa

41 views
14:09

ASCO GU 2023 Exposure Toxicity and Response Relationship of Cabozant…

ASCO GU 2023 Conference Coverage

Y. Vano

90 views
04:20

ASCO GU 2023 CaboPoint Phase 2 Study: Cabozantinib After Checkpoint …

ASCO GU 2023 Conference Coverage

L. Albiges

128 views
05:32

ASCO GU 2023 Cell-Free utDNA to Detect MRD Prior to Repeat-Transuret…

ASCO GU 2023 Conference Coverage

K. Rose

77 views
14:01

ASCO GU 2023 Active Surveillance for Favorable Intermediate-Risk Pro…

ASCO GU 2023 Conference Coverage

A. D'Amico

153 views
12:05

ASCO GU 2023 Novel Guidelines for PSMA PET Staging of Prostate Cance…

ASCO GU 2023 Conference Coverage

D. Nanus

329 views
12:01

ASCO GU 2023 Sequential Enfortumab Vedotin After Platinum-Based Chem…

ASCO GU 2023 Conference Coverage

P. Cen

251 views
08:15

ASCO GU 2023 3-Year Follow-Up From The Phase 3 CheckMate 9ER Trial: …

ASCO GU 2023 Conference Coverage

M. Burotto

369 views
15:17

ASCO GU 2023 Systemic Therapy for Recurrent Metastatic RCC: Beyond S…

ASCO GU 2023 Conference Coverage

T. Zhang

827 views
02:42

ASCO GU 2023 Day Three Highlights With Resident Jindal and Dr. Park

ASCO GU 2023 Conference Coverage

T. Jindal, C. Park

37 views
22:25

ASCO GU 2023 Prostate and Bladder Updates With Dr. Jones and Dr. Park

ASCO GU 2023 Conference Coverage

R. Jones, C. Park

129 views
09:22

ASCO GU 2023: Dr. Park and Dr. Grivas Discuss TROPHY-U-01 and EV-201…

ASCO GU 2023 Conference Coverage

P. Grivas, C. Park

661 views
08:13

ASCO GU 2023 Dr. Plimack and Dr. Park Discuss Over-Treating in Muscl…

ASCO GU 2023 Conference Coverage

E. Plimack, C. Park

627 views
08:59

ASCO GU 2023 Treatment Outcomes With New Targeted Agents in Advanced…

ASCO GU 2023 Conference Coverage

V. Koshkin, C. Park

221 views
06:04

ASCO GU 2023 Phase II Study Rucaparib Monotherapy in Pts With nmHSPC…

ASCO GU 2023 Conference Coverage

K. Sahu, C. Park

113 views
06:34

ASCO GU 2023 Dr. Flaig and Dr. Park Discuss Updates in Prostate and …

ASCO GU 2023 Conference Coverage

T. Flaig, C. Park

446 views
05:18

ASCO GU 2023: Dr. Miron and Dr. Park Discuss Kidney and Bladder Upda…

ASCO GU 2023 Conference Coverage

B. Miron, C. Park

509 views
06:19

ASCO GU 2023: Dr. Park and Dr. Gupta Discuss the BLASST-1 Study

ASCO GU 2023 Conference Coverage

S. Gupta, C. Park

229 views
09:12

ASCO GU 2023 Longitudinal Detection of ctDNA in Patients With Advanc…

ASCO GU 2023 Conference Coverage

A. Basu, C. Park

249 views
03:08

ASCO GU 2023 Day Two Highlights With Dr. Talukder and Dr. Park

ASCO GU 2023 Conference Coverage

R. Talukder, C. Park

35 views
10:32

ASCO GU 2023 Dr. Rettig and Dr. Park Discuss Prostate Cancer Updates

ASCO GU 2023 Conference Coverage

M. Rettig, C. Park

223 views
05:57

ASCO GU 2023 Comparison of ctDNA Between African-American and Caucas…

ASCO GU 2023 Conference Coverage

A. Jang, C. Park

242 views
10:01

ASCO GU 2023 Bladder Cancer Highlights With Dr. Sonpavde and Dr. Park

ASCO GU 2023 Conference Coverage

G. Sonpavde, C. Park

620 views
01:53

ASCO GU 2023 Day One Highlights With Dr. Zakharia

ASCO GU 2023 Conference Coverage

Y. Zakharia

83 views